Rockwell Medical (RMTI) Other financing activities (2012 - 2023)

Rockwell Medical (RMTI) reported Other financing activities of -$38000.0 for Q4 2023, down 188.37% quarter-over-quarter from $43000.0 in Q3 2023.

Rockwell Medical (RMTI) Other financing activities (2012 - 2023) Analysis & Trends

Rockwell Medical has reported Other financing activities for 5 years, with the latest figure at -$38000.0 in Q4 2023.

  • For the quarter ending Q4 2023, Other financing activities changed N/A year-over-year to -$38000.0; the trailing twelve-month figure through Dec 2024 stood at $5000.0 (changed 0.0% YoY), and the FY2023 full-year result was $5000.0, down 95.28% from the prior year.
  • Other financing activities for Q4 2023 stood at -$38000.0, down from $43000.0 in the prior quarter.
  • The five-year high for Other financing activities was $969000.0 in Q2 2020, with the low at -$38000.0 in Q4 2023.
  • Historically, Other financing activities has averaged $269675.6 across 3 years, with a median of $43000.0 in 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Rockwell Medical 26.01 Mn 2.12 Mn 2.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 -38,000.00
Dec 31, 2023 -38,000.00
Sep 30, 2023 43,000.00
Sep 30, 2023 43,000.00
Jun 30, 2022 378.00
Jun 30, 2022 378.00
Jun 30, 2020 969,000.00
Jun 30, 2020 969,000.00
Mar 31, 2020 374,000.00
Mar 31, 2020 374,000.00
Dec 31, 2013 -500,776.00
Dec 31, 2013 -500,776.00
Sep 30, 2013 28,497.00
Sep 30, 2013 28,497.00
Jun 30, 2013 -18,721.00
Jun 30, 2013 -18,721.00
Dec 31, 2012 2.40 Mn
Dec 31, 2012 2.40 Mn